Botensilimab (Fc-enhanced anti–cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti–PD-1 antibody) in Patients With Relapsed/Refractory Metastatic Sarcomas ASCO Guidelines ...
However, with all the paces you’re putting it through, it's inevitable that it may show signs of wear and tear over time. And ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback